Market Tracker

06/23 5:16pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.44
Delayed Data
As of Jun 23
 +0.10 / +1.36%
Today’s Change
5.70
Today|||52-Week Range
8.94
+21.57%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close7.34
Today’s open7.42
Day’s range7.32 - 7.45
Volume13,760
Average volume (3 months)36,406
Market cap$98.9M
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-29.85%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales142.00
Price/Book3.75

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...-0.10-1.80%
VCELVericel Corp+0.15+5.26%
ACRXAcelRx Pharmaceutica...-0.25-10.42%
ZFGNZafgen Inc-0.09-2.37%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateJuly 5, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$641.0K
Annual profit (last year)-$11.0M
Net profit margin-1,710.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts